Praxis Precision Medicines Inc (PRAX)
45.27
+0.06
(+0.13%)
USD |
NASDAQ |
May 17, 16:00
45.27
0.00 (0.00%)
After-Hours: 20:00
Praxis Precision Medicines Total Assets (Quarterly): 250.41M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 250.41M |
December 31, 2023 | 87.95M |
September 30, 2023 | 106.72M |
June 30, 2023 | 133.50M |
March 31, 2023 | 98.38M |
December 31, 2022 | 115.13M |
September 30, 2022 | 136.90M |
June 30, 2022 | 180.42M |
March 31, 2022 | 239.50M |
Date | Value |
---|---|
December 31, 2021 | 292.75M |
September 30, 2021 | 324.41M |
June 30, 2021 | 353.51M |
March 31, 2021 | 279.25M |
December 31, 2020 | 303.18M |
September 30, 2020 | 119.55M |
June 30, 2020 | 22.65M |
December 31, 2019 | 47.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
22.65M
Minimum
Jun 2020
353.51M
Maximum
Jun 2021
181.88M
Average
136.90M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
Catalyst Pharmaceuticals Inc | 646.68M |
Regeneron Pharmaceuticals Inc | 34.37B |
Atossa Therapeutics Inc | 91.09M |
ADMA Biologics Inc | 350.88M |
Viking Therapeutics Inc | 967.52M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 20.73M |
Shareholders Equity (Quarterly) | 229.68M |
Current Ratio | 11.27 |